Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Emerging Gold Standard?
San Francisco - More than two decades after collagen launched a revolution in filling facial wrinkles, the FDA is expected to approve the soft filler hyaluronic acid (Restylane, Q-Med) within the next few months. The approval will be partly based on a phase III study that showed it provides longer-lasting correction of nasolabial folds than collagen.
Related Videos
Related Content
